Avid Other Stockholder Equity vs Total Liab Analysis
CDMO Stock | USD 12.30 0.05 0.41% |
Avid Bioservices financial indicator trend analysis is way more than just evaluating Avid Bioservices prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avid Bioservices is a good investment. Please check the relationship between Avid Bioservices Other Stockholder Equity and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.
Other Stockholder Equity vs Total Liab
Other Stockholder Equity vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avid Bioservices Other Stockholder Equity account and Total Liab. At this time, the significance of the direction appears to have weak relationship.
The correlation between Avid Bioservices' Other Stockholder Equity and Total Liab is 0.33. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Liab in the same time period over historical financial statements of Avid Bioservices, assuming nothing else is changed. The correlation between historical values of Avid Bioservices' Other Stockholder Equity and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Avid Bioservices are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Other Stockholder Equity i.e., Avid Bioservices' Other Stockholder Equity and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.33 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Other Stockholder Equity
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Avid Bioservices' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avid Bioservices current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.At this time, Avid Bioservices' Selling General Administrative is very stable compared to the past year. As of the 25th of November 2024, Discontinued Operations is likely to grow to about 1 M, while Sales General And Administrative To Revenue is likely to drop 0.17.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 21.2M | 27.9M | 26.0M | 28.1M | Cost Of Revenue | 82.9M | 117.8M | 132.6M | 139.2M |
Avid Bioservices fundamental ratios Correlations
Click cells to compare fundamentals
Avid Bioservices Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avid Bioservices fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 107.6M | 265.5M | 429.8M | 451.1M | 336.6M | 353.4M | |
Short Long Term Debt Total | 26.9M | 118.2M | 182.5M | 189.2M | 207.8M | 218.2M | |
Other Current Liab | 3.8M | 8.2M | 9.5M | 11.2M | 8.7M | 9.1M | |
Total Current Liabilities | 44.5M | 70.9M | 75.8M | 73.7M | 70.6M | 74.1M | |
Total Stockholder Equity | 41.9M | 77.7M | 174.5M | 189.5M | 60.9M | 38.7M | |
Property Plant And Equipment Net | 47.2M | 56.1M | 129.8M | 220.1M | 227.7M | 239.1M | |
Net Debt | (9.4M) | (51.7M) | 56.4M | 150.7M | 169.7M | 178.2M | |
Retained Earnings | (571.1M) | (559.9M) | (431.4M) | (430.8M) | (571.9M) | (543.3M) | |
Accounts Payable | 5.9M | 9.3M | 9.5M | 24.6M | 20.7M | 21.7M | |
Non Current Assets Total | 47.9M | 57.7M | 249.8M | 338.6M | 232.6M | 244.2M | |
Net Receivables | 11.9M | 25.0M | 25.9M | 27.9M | 29.0M | 30.5M | |
Common Stock Shares Outstanding | 56.3M | 59.4M | 70.5M | 63.8M | 63.2M | 66.4M | |
Liabilities And Stockholders Equity | 107.6M | 265.5M | 429.8M | 451.1M | 336.6M | 353.4M | |
Non Current Liabilities Total | 21.2M | 116.8M | 179.6M | 187.9M | 205.1M | 215.4M | |
Other Current Assets | 712K | 1.1M | 1.9M | 2.1M | 6.5M | 6.8M | |
Other Stockholder Equity | 612.9M | 637.5M | 605.8M | 620.2M | 632.7M | 364.2M | |
Total Liab | 65.7M | 187.8M | 255.3M | 261.6M | 275.7M | 289.5M | |
Property Plant And Equipment Gross | 47.2M | 56.1M | 129.8M | 220.1M | 264.3M | 277.5M | |
Total Current Assets | 59.8M | 207.8M | 180.0M | 112.5M | 104.0M | 109.2M | |
Cash | 36.3M | 169.9M | 126.2M | 38.5M | 38.1M | 36.3M | |
Cash And Short Term Investments | 36.3M | 169.9M | 126.2M | 38.5M | 38.1M | 36.3M | |
Inventory | 10.9M | 11.9M | 26.1M | 43.9M | 30.4M | 31.9M | |
Short Term Debt | 5.6M | 2.7M | 3.5M | 142.0M | 2.8M | 2.7M | |
Other Assets | 652K | 1.6M | 120.1M | 118.5M | 136.2M | 143.0M | |
Property Plant Equipment | 27.1M | 37.5M | 93.0M | 177.4M | 204.0M | 214.2M | |
Current Deferred Revenue | 29.1M | 50.8M | 53.8M | 37.4M | 39.9M | 41.9M | |
Retained Earnings Total Equity | (571.1M) | (559.9M) | (431.4M) | (430.8M) | (387.7M) | (407.1M) | |
Deferred Long Term Liab | 2.2M | 2.1M | 900K | 3.5M | 4.0M | 4.2M | |
Net Tangible Assets | 41.9M | 77.7M | 174.5M | 189.5M | 217.9M | 228.8M | |
Capital Surpluse | 612.9M | 637.5M | 605.8M | 620.2M | 713.3M | 623.0M |
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving against Avid Stock
0.73 | TCHH | Trustcash Holdings | PairCorr |
0.61 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.6 | EQ | Equillium | PairCorr |
0.6 | VALN | Valneva SE ADR | PairCorr |
0.54 | PFE | Pfizer Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (2.29) | Revenue Per Share 2.245 | Quarterly Revenue Growth 0.065 | Return On Assets (0.03) |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.